Ceranza G Daans, Elske Hoornenborg, Kristin B de Haseth, Müjde Özer, Mark-Bram Bouman, Elfi Conemans, Baudewijntje P C Kreukels, Martin den Heijer, Wouter B van der Sluis
{"title":"HIV Prevalence and High-Risk Subgroup Identification in Transgender Women Who Undergo Primary Vaginoplasty in the Netherlands.","authors":"Ceranza G Daans, Elske Hoornenborg, Kristin B de Haseth, Müjde Özer, Mark-Bram Bouman, Elfi Conemans, Baudewijntje P C Kreukels, Martin den Heijer, Wouter B van der Sluis","doi":"10.1089/trgh.2021.0059","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Worldwide, transgender women (TGW) bear a high HIV burden. Limited data are available on HIV prevalence and risk factors among TGW in western European countries. Our aim is to assess the prevalence of TGW living with HIV who underwent primary vaginoplasty in an academic reference hospital and to identify high-risk subgroups.</p><p><strong>Methods: </strong>All TGW who underwent primary vaginoplasty between January 2000 and September 2019 at our institution were identified. A retrospective chart study was conducted, recording the medical history, age at vaginoplasty, region of birth, use of medication, injecting drug use, history of pubertal suppression, HIV status, and sexual preference at time of surgical intake. High-risk subgroups were identified using logistic regression analysis.</p><p><strong>Results: </strong>Between January 2000 and September 2019, a total of 950 TGW underwent primary vaginoplasty, of whom 31 (3.3%) individuals were known to live with HIV. Prevalence of HIV was higher in TGW born outside of Europe (20/145, 13.8%) than among those born in Europe (11/805, 1.4%), <i>p</i><0.001. In addition, having a sexual preference toward men was significantly associated with HIV. None of the TGW living with HIV had a history of puberty suppression.</p><p><strong>Conclusion: </strong>The HIV prevalence in our study population is higher than the reported HIV prevalence in cisgender population in the Netherlands but lower than reported in previous studies in TGW. Further studies should investigate the need and feasibility of routine HIV testing of TGW in Western countries.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"8 3","pages":"226-230"},"PeriodicalIF":2.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277977/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/trgh.2021.0059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Worldwide, transgender women (TGW) bear a high HIV burden. Limited data are available on HIV prevalence and risk factors among TGW in western European countries. Our aim is to assess the prevalence of TGW living with HIV who underwent primary vaginoplasty in an academic reference hospital and to identify high-risk subgroups.
Methods: All TGW who underwent primary vaginoplasty between January 2000 and September 2019 at our institution were identified. A retrospective chart study was conducted, recording the medical history, age at vaginoplasty, region of birth, use of medication, injecting drug use, history of pubertal suppression, HIV status, and sexual preference at time of surgical intake. High-risk subgroups were identified using logistic regression analysis.
Results: Between January 2000 and September 2019, a total of 950 TGW underwent primary vaginoplasty, of whom 31 (3.3%) individuals were known to live with HIV. Prevalence of HIV was higher in TGW born outside of Europe (20/145, 13.8%) than among those born in Europe (11/805, 1.4%), p<0.001. In addition, having a sexual preference toward men was significantly associated with HIV. None of the TGW living with HIV had a history of puberty suppression.
Conclusion: The HIV prevalence in our study population is higher than the reported HIV prevalence in cisgender population in the Netherlands but lower than reported in previous studies in TGW. Further studies should investigate the need and feasibility of routine HIV testing of TGW in Western countries.
目的:在世界范围内,变性妇女(TGW)的艾滋病负担很重。有关西欧国家变性女性中 HIV 感染率和风险因素的数据十分有限。我们的目的是评估在一家学术参考医院接受初级阴道成形术的 TGW 艾滋病感染率,并确定高风险亚群:方法:对2000年1月至2019年9月期间在我院接受初次阴道成形术的所有TGW进行识别。我们进行了一项回顾性病历研究,记录了手术时的病史、阴道成形术时的年龄、出生地区、药物使用情况、注射毒品使用情况、青春期抑制史、HIV 感染情况和性偏好。通过逻辑回归分析确定了高风险亚组:2000年1月至2019年9月期间,共有950名女性同性恋者接受了初级阴道成形术,其中31人(3.3%)已知感染了艾滋病毒。在欧洲以外出生的 TGW 中,HIV 感染率(20/145,13.8%)高于在欧洲出生的 TGW(11/805,1.4%):我们研究人群中的 HIV 感染率高于荷兰报告的顺性别人群中的 HIV 感染率,但低于以往研究中报告的 TGW 感染率。进一步的研究应探讨在西方国家对 TGW 进行常规 HIV 检测的必要性和可行性。